Based on the current findings, our future investigations will focus on further validation of the role of STAT1 in conferring resistance to oHSV in neuroblastoma, and the utility of combining oHSV with small molecular inhibitors of STAT signaling. This evidence concerns the gene SOAT1 and neuroblastoma.